Lykan Bioscience will expand its plant in Hopkinton, Massachusetts to support the growing demand for cell therapy development and production. Lykan Bioscience, a contract development manufacturing organization (CDMO) focused on cell-based therapies, will add seven cleanrooms with capabilities for autologous and allogenic production at its Hopkinton plant. “The demand in the cell therapy segment is robust, we brought the original 8 cGMP suites online in January of this year and we believe the original capacity will be fully allocated to…